Objective: The surfacing of thoughts and depressive affect associated with the prospect of death are prevalent among patients with advanced cancer. Because death cognitions and associated negative affect occur along an adaptive-less adaptive continuum, it is essential that valid and reliable instruments are available to measure death depression. The present study aimed to determine the psychometric properties of the Death Depression Scale among Iranian patients with advanced cancer. Methods: About 497 cancer patients completed a Persian version of the 21-item Death Depression Scale-Revised. The face, content and construct validity of the scale were ascertained. Reliability was also assessed using internal consistency, construct reliability and intra-class correlation coefficient (ICC). Results: Construct validity determined one factor with an eigenvalue greater than 1. The model had a good fit (χ 2 (179, N = 248) = 520.345, P < 0.001; χ 2 /df = 2.907, CFI = 0.916, TLI = 0.902, IFI = 0.917, SRMR = 0.049 and RMSEA = 0.088 (90% confidence interval = 0.079-0.097)) with all factors loadings greater than 0.5 and statistically significant. The internal consistency, construct reliability and ICC were greater than 0.70. Convergent validity of the scale was demonstrated. Conclusions: Findings revealed that the Persian version of the Death Depression Scale-Revised is valid and reliable, and may be used to assess and evaluate death depression in Iranian patients with advanced cancer.
Introduction
A diagnosis of cancer can result in despair, grief and aversive thoughts about death (1) . Most patients with cancer are affected by psychological symptoms to varying degrees (2) . Factors that are shown to influence the severity of psychological morbidity are sociodemographic characteristics (e.g. gender, age and education level) (3), level of social support (4), disease-related factors (5) (6) (7) (8) and contextual/ cultural factors such as religiosity (9) .
Both disease and treatment factors are implicated in reducing the physical and psychological wellbeing of patients with cancer (10) . Concerns about death may potentiate negative affect, negatively impact communication and alienate patients from their care providers in patients without clinically identified mental health problems (1) . Unrelenting concerns about death may lead to death depression, characterized by prolonged perceptions of sadness, loss and grief about impending death that negatively impacts function and a source of distress that is recognized in cancer survivors (11) (12) (13) .
Studies have shown that depressive symptoms are prevalent, estimated to affect 10-20% of patients with cancer (14, 15) . Patients with clinical depression may lose their motivation for survival and thus concede to the disease (1) . In general, the occurrence of comorbid clinical depression with a cancer diagnosis negatively affects social, mental, and physical health, treatment tolerance, and even disease progression (16) .
Due to the potentially negative effects associated with the development of death depression symptoms, there is a clinical need for specialized tools for evaluating and distinguishing death depression in patients with cancer. Addressing death concerns including perceptions of sadness, grief, and loss and intervening in a timely fashion may prevent the development of more serious clinical depressive disorders (17, 18) .
While empirical researches have indicated that the Death Depression Scale (DDS) has been evaluated extensively in Spanish and English in healthy and clinical population samples (18) (19) (20) (21) , little research has examined the DDS in Iranian cancer patients. It is recognized that Iran's unique regional and cultural context may have a significant effect on people's perceptions about death and associated depressive symptoms (22) . Therefore, it is essential to have a specialized tool with an accurate assessment and diagnostic capacity for evaluating death depression in non-clinically depressed patients with cancer. With such a tool, health practitioners will be able to design more effective care plans based on their accurate evaluation of death depression. Therefore, the present study aims to verify the psychometric properties of the Death Depression Scale-Revised (DDS-R) in Iranian patients with advanced cancer.
Patients and methods
The cross-cultural psychometrics study was conducted in 2016 (March-June) and included 497 patients with advanced cancer from Oncology Units of Imam Khomeini Hospital (Sari, Iran) and the Oncology Center of Kerman (Iran). During the 4-month period, about 900 patients were admitted to these hospitals. In order for a participant to be included in this study, he/she was required to meet the following criteria: (i) diagnosis of advanced cancer, (ii) able to read and write Persian, (iii) alert, oriented and cognitively intact and (iv) have no co-morbid psychiatric problems (such as schizophrenia, post-traumatic stress disorder, dementia, and major depressive disorder) and physical symptom experiences which could restrict participation in the study. The reason for including patients with no clinical depression was to study patients having issues with coping with forthcoming death rather than death depression in depressed patients. Patients who were excluded from the study included those: (i) who transferred to another hospital; (ii) with critical co-occurring conditions such as drug or alcohol addiction; and (iii) with language and/or physical problems that impeded their ability to perform the study requirements. As suggested in the literature, the minimum sample size for conducting factor analysis was determined to be at least 5 to 10 times of the number of tested items (23) . Out of the represented patients (n = 900), 210 were excluded (receiving surgery, radiotherapy or chemotherapy [n = 100], presence of comorbid psychiatric problems [n = 90] and non-literate [n = 20]). Of the remaining 690 eligible participants, 497 patients agreed to participate (response rate of 72.02). Participants completed the DDS-R following admission. The purpose of the study was described to the participants and the questionnaires were distributed to them.
Ethical considerations
The study was approved by the Ethics Committee of Mazandaran University of Medical Sciences, Sari, Iran (Ethics Code: IR.MAZUMS. REC.95.106). Patients were informed about the study aims and procedures. Moreover, they were ensured that participation was voluntary and that it would not affect their medical care. The confidentiality of patients' information was guaranteed. Informed consent was obtained from all participants.
All participants completed demographic questionnaires and the translated DDS-R to assess for symptoms of death depression. Prior to initiating translation of the DDS-R, written permission for conducting the study was obtained from Dr. Templer. The World Health Organization protocol was used to translate the DDS-R into Persian (24) . We employed the forward-backward translation technique for translating the scale from English into Persian. Accordingly, two English-Persian translators were invited to independently translate the DDS-R from English into Persian. An expert panel consisting of doctorally prepared researchers and two translators assessed and unified the two translations and produced a single Persian translation of DDS-R. Thereafter, a Persian-English translator was asked to backtranslate the Persian DDS-R into English. This English version of the DDS-R was sent to Dr. Templer. He confirmed the correctness of the translation and the similarity of our English DDS-R with the original English DDS-R. The DDS-R includes 21 items which are scored on a 5-point Likert scale from 1 (Completely disagree) to 5 (Completely agree). Consequently, the total score of the scale ranges from 21 to 105. Lower scores indicate lesser degrees of death depression (25) .
For validity assessment of this scale, both face and content validity (Qualitative and Quantitative) as well as construct validity (Exploratory and Confirmatory) were used.
Face validity assessment
The face validity of the Persian DDS-R was assessed both qualitatively and quantitatively.
Qualitative face validity assessment
For assessing the qualitative face validity of the Persian DDS-R, 10 patients with an advanced cancer diagnosis were invited to assess and comment on the appropriateness, difficulty, relevance and ambiguity of the survey items. Moreover, the necessary time for completing the scale was calculated in this step. The scale was amended based on the patients' comments.
Quantitative face validity assessment
The item impact technique was adopted for assessing the quantitative face validity of the Persian DDS-R. The same ten patients from the qualitative face validity assessment were asked to determine the importance of the items on a Likert-type scale from 1 (Not important) to 5 (Completely important). The item impact score of each item was calculated by using the following formula, Importance × Frequency (%). In this formula, the frequency is equal to the number of patients who had ascribed a score of 4 or 5 to the intended item and the importance was equal to scores of 4 or 5. If the impact score of the each item was greater than 1.5, the item was considered as suitable and it was maintained in the scale (26, 27) .
Content validity assessment
The content validity of the Persian DDS-R was also assessed both qualitatively and quantitatively.
Qualitative content validity assessment
In this step, the Persian DDS-R was provided to 15 experts (nine nursing doctorates, two psychiatrists, two clinical psychologists and two oncologists), who were asked to assess and comment on the wording, item allocation and scaling of the items (28) . We adjusted the DDS-R according to their respective expertise.
Quantitative content validity assessment
The quantitative content validity of the scale was assessed through calculating Content Validity Ratio (CVR) and Content Validity Index (CVI) for the items. The CVR reflects whether the scale items are essential or not. Accordingly, the above-mentioned fifteen experts were asked to rate the essentiality of the DDS-R items on a 3-point scale as follows: Not essential: 1; Useful but not essential: 2; and Essential: 3 (29) . The CVR of each item was calculated by using the following formula: CVR = (n e -(N/2))/(N/2). In this formula, N and n e are, respectively, equal to the total number of experts and the number of experts who score the intended item as 'Essential'. According to Lawshe (1975) , when the number of panelists is 15 members, the minimum acceptable CVR is equal to 0.49 (30) .
On the other hand, CVI shows the degree to which the items of the intended scale are simple, relevant and clear. The CVI can be calculated for each item of a scale (Item-level or I-CVI) and for the overall scale (Scale-level or S-CVI). Accordingly, we asked the same 15 panelists to rate the simplicity, relevance and clarity of the DDS-R items on a 4-point scale from 1 to 4. The four points for rating the relevance of the items were 'not relevant', 'somewhat relevant', 'quite relevant' and 'highly relevant', which were scored as 1, 2, 3 and 4, respectively. The I-CVI of each item was calculated by dividing the number of panelists who had rated that item as 3 or 4 by the total number of the panelists. Lynn et al. (2006) noted that when the number of panelists is equal to 15, the items which acquire an I-CVI value of 0.79 or greater are considered as appropriate (31) .
Construct validity assessment
To assess construct validity, the factor structure of the Persian DDS-R was examined by conducting a maximum likelihood exploratory factor analysis (EFA) followed by a varimax rotation with SPSS 22 (SPSS Inc., Chicago, IL, USA). About 497 patients with cancer were asked to complete the Persian DDS-R. The Kaiser-Meyer-Olkin (KMO) test and the Bartlett's test of sphericity were used to check the appropriateness of the study sample and the factor analysis model. The number of factors was determined based on eigenvalues and scree plot. Items with absolute loading values of 0.3 or greater were regarded as appropriate. Also, eigenvalues of one or less were ignored (32) .
The factor structure obtained from the EFA was then examined using a confirmatory factor analysis (CFA) conducted with AMOS 19. Jaccard and Wan (1996) 
Reliability assessment
The reliability of the Persian DDS-R was first assessed through evaluating its internal consistency and calculating Cronbach's alpha (α), theta (θ), and McDonald Omega (Ω) Coefficient for absolute agreement for the individual items and domains (37) . Reliability of 0.7 or greater shows satisfactory internal consistency (38) . The CR of factor was then assessed in which values between 0.6 and 0.7 were accepted providing other indicators were also acceptable (39, 40) . Intra-class correlation coefficients (ICCs) was used to establish the test-retest reliability of the DDS-R over an interval of 2 weeks using two-way mixed ICC for absolute agreement at the level of individual items. The results were interpreted as follows: 0-0. 
Multivariate normality and outliers
Univariate distributions were examined for outliers, skewness and kurtosis. Multivariate distributions were evaluated for normality and multivariate outliers (42) . Multivariate normality can be evaluated through the use of the Mardia's coefficient of multivariate kurtosis. A Mardia's coefficient greater than 8 was an indication of deviation from normal distribution (43) . Multivariate outliers were evaluated through evaluation of Mahalanobis distance (44) . Items with Mahalanobis distance with P < 0.001 were considered as multivariate outliers (45) . Table 1 describes the demographic profiles of the respondents. The respondents were predominately married (n = 354, 71.2 %) with a mean age of 47.54 years. Among them, 52.1% (n = 259) were female.
Results
The impact score, CVR and I-CVI values of all 21 items of the Persian DDS-R were, respectively, greater than 1.5, 0.49 and 0.79. Therefore, none of the items were excluded in these initial steps of psychometric evaluation. Table 2 shows the results of performing maximum likelihood EFA on the DDS-R using the first dataset consisting of 249 participants. The KMO was 0.951, and the Bartlett's test of sphericity was significant (P < 0.001, 4485.458, df = 210) indicating that the sampling was adequate. Using a scree plot, which is shown in Fig. 1 and considering factors with eigenvalue greater than one, EFA extracted one factor consisting of 21 items together accounting for 58.21% of the variance. The factor loading of all items was greater than 0.5 ranging from 0.529 to 0.833.
Next, the factor structure obtained with EFA was assessed and validated using maximum likelihood CFA and the second dataset with a sample of 248 participants. Based on the modification indices, ten pairs of measurement errors (between items: 2 and 3; 8 and 9; 9 and 10; 10 and 13; 11 and 12; 12 and 13; 13 and 14; 15 and 16; 16 and 17; and between items 19 and 21) were allowed to freely co-vary. Figure 2 Table 2 showed that the AVE of the construct exceeded 0.5 and the CR was greater than AVE, fulfilling the requirements of convergent validity.
Discussion
The purpose of the present study was to evaluate the psychometric properties of the Persian version of the DDS-R in Iranian patients with advanced cancer. EFA and CFA were used to investigate and then confirm the underlying structure of the scale. EFA showed that the DDS-R is a one-dimensional construct in this sample of patients. (2005) , who investigated the Spanish form of the scale found a fourdimensional structure. The factors were called anergia (abnormal lack of energy) and existential, vacuum (emptiness), death sadness, others' death and anhedonia (46) . Two other studies conducted in healthy populations also confirmed the four and three dimensionality of the scale (21, 47) . In previous Iranian studies, participants were homogenous (university students, nurses) and had not experienced chronic diseases and life-threatening conditions. Based on the items loading in the EFA, the latent factor was labeled 'death sadness'. It comprised of items reflecting feelings of losing energy, hopelessness and sadness when thinking about death. Previous studies have also identified this factor for the DDS (18, 25, 47, 48) . According to Kubler-Ross (1969) , health professionals who work directly with advanced cancer patients report that sadness, suffering, hopelessness and loss are components of depression that result from the conception of one's own death, the death of significant others and death in general (49) . Moreover, factors such as the severity of disease and separation from loved ones can heighten patients' death-related worries and sadness (50, 51) . Finally, it is recognized that patients' worry and despair may be influenced by thoughts regarding the rapid passage of time, the brevity of life, the potential for an imminent painful death and fear of the unknown (52) . Therefore, personal cognitions stemming from life experiences that impact hopes, fears and concerns about the nature and meaning of death may contribute to higher depressive symptoms about death (53) .
The CFA model used to determine the validity of the Persian version of the DDS-R confirmed the final factor construct of the present scale. To the best of our knowledge, there are no other studies to compare the results with the present one. Chi-square goodness-of-fit test was approaching significance in the sample size with more than 200 participants (54) .
Coefficients of internal consistency and CR of the DDS-R showed that the Persian version of the DDS-R has solid reliability in this sample of Iranian cancer patients. The 4 weeks test-retest correlation was estimated to be 0.87 (18) . The Cronbach's alpha coefficient of the original version was 0.92 as reported by Templer (2002) . Templer stated that the significant correlation between the DDS-R and other measures of depression and anxiety were appropriate, and the relation between the Likert form and the true-false part was 0.85 (25) . Moreover, two other Iranian studies conducted among university students and nurses calculated Cronbach's alpha coefficients and test-retest method to be 0.93 and 0.76, respectively (21, 47) .
The present study estimated AVE for assessment of convergent validity. The findings showed necessary construct fulfillment. When a construct is related to other theoretically relevant constructs, it is said to have convergent validity (55) . The DDS-R has been evaluated in other studies for its relationships with other theoretically related constructs such as anxiety and hopelessness (56) (57) (58) . Previous studies have also supported a four-factor model for the DDS-R, with factors including death sadness, anergia, existential vacuum and anhedonia (25, 46, 59) .
Implications
The Persian version of the DDS-R has been demonstrated in this article to be a useful tool for the assessment of death-related depression in Iranian patients experiencing advanced cancer. The psychometric properties of this scale indicated that this is a reliable and valid measure which can be used in Persian populations of patients with cancer.
Limitations
This study incorporated 497 patients with advanced cancer in Iran, so generalizability becomes less robust if generalized outside of this sample. While Farsi is spoken in other geographical areas, the measure may not be accurate with different groups of patients. It is essential that replicative studies to be conducted, both in cancer populations and in other Iranian samples of individuals facing life- threatening or life-limiting illness. It is also important to note that patients who participated in this study were not diagnosed with clinical depression. Death depression and its negative sequelae may be higher among clinically depressed patients with advanced cancers.
This study confirmed acceptable psychometric properties and the factor structure of the DDS-R in an Iranian sample. Given these findings, the scale can be used as a valid and reliable tool for the assessment of death depression experienced by Iranian cancer patients.
Funding
Mazandaran University of Medical Sciences and an extension of Taylor's University Research Grant (TRGS/ERFS/1/2015/TBS/014) funded this study. We want to hereby extend our sincere gratitude to the patients who helped to make this research possible.
